Bluejay Diagnostics (BJDX) Free Cash Flow (2020 - 2026)
Bluejay Diagnostics recorded quarterly Free Cash Flow of -$1.6 million in Q1 2026, down 10.54% quarter-over-quarter from -$1.5 million in Q4 2025, and down 35.73% year-over-year from -$2.5 million in Q1 2025.
Bluejay Diagnostics' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$1.6 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 35.73% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at -$6.5 million (up 7.17% YoY), while the FY2025 annual figure was -$6.2 million, up 23.38% from the prior year.
- Free Cash Flow came in at -$1.6 million for Q1 2026 at Bluejay Diagnostics, down from -$1.5 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$1.2 million in Q1 2025 to a low of -$3.3 million in Q1 2023.
- A 5-year average of -$2.0 million and a median of -$1.9 million in 2022 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow plunged 416.24% in 2022 and surged 49.31% in 2024, its largest moves.
- Bluejay Diagnostics' Free Cash Flow stood at -$3.2 million in 2022, then increased by 9.96% to -$2.9 million in 2023, then jumped by 49.31% to -$1.5 million in 2024, then retreated by 0.17% to -$1.5 million in 2025, then declined by 10.54% to -$1.6 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$1.6 million, -$1.5 million, and -$1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | -1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.61 Mn |
| Mar 31, 2026 | -1.61 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Mar 31, 2025 | -1.18 Mn |
| Mar 31, 2025 | -1.18 Mn |
| Dec 31, 2024 | -1.45 Mn |
| Dec 31, 2024 | -1.45 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Mar 31, 2024 | -2.34 Mn |
| Mar 31, 2024 | -2.34 Mn |
| Dec 31, 2023 | -2.87 Mn |
| Dec 31, 2023 | -2.87 Mn |
| Sep 30, 2023 | -1.20 Mn |
| Sep 30, 2023 | -1.20 Mn |
| Jun 30, 2023 | -1.68 Mn |
| Jun 30, 2023 | -1.68 Mn |
| Mar 31, 2023 | -3.27 Mn |
| Mar 31, 2023 | -3.27 Mn |
| Dec 31, 2022 | -3.18 Mn |
| Dec 31, 2022 | -3.18 Mn |
| Sep 30, 2022 | -2.05 Mn |
| Sep 30, 2022 | -2.05 Mn |
| Jun 30, 2022 | -1.78 Mn |
| Jun 30, 2022 | -1.78 Mn |
| Mar 31, 2022 | -1.92 Mn |
| Mar 31, 2022 | -1.92 Mn |
| Dec 31, 2021 | -2.54 Mn |
| Dec 31, 2021 | -2.54 Mn |
| Sep 30, 2021 | -1.12 Mn |
| Sep 30, 2021 | -1.12 Mn |
| Jun 30, 2021 | -356,181.00 |
| Jun 30, 2021 | -356,181.00 |
| Mar 31, 2021 | -372,620.00 |
| Mar 31, 2021 | -372,620.00 |
| Dec 31, 2020 | -154,856.00 |
| Dec 31, 2020 | -154,856.00 |